By Mary Ellen Podmolik | Accretive Health, Inc. announced Wednesday the closing of of its 11.5 million-share initial public offering at a price of $12 a share.
The Chicago-based provider of healthcare revenue cycle management services said it sold about 7.7 million shares and shareholders sold an additional 3.8 million shares of common stock, including the underwriters’ option to buy additional shares that was fully exercised.